Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Prepublished online as a Blood First Edition Paper on April 24, 2003; DOI 10.1182/blood-2002-07-2206.

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2002-07-2206v1
102/5/1745    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Crawford, K.
Right arrow Articles by Alper, C. A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Crawford, K.
Right arrow Articles by Alper, C. A
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted July 26, 2002
Accepted March 3, 2003

CD2 engagement induces dendritic cell activation: implications for immune surveillance and T-cell activation

Keith Crawford, Aleksandra Stark, Betsy Kitchens, Kerry Sternheim, Vassilios Pantazopoulos, Ellen Triantafellow, Zhigang Wang, Beldav Vasir, Charles E Larsen, Dana Gabuzda, Ellis Reinherz, and Chester A Alper*

The Center for Blood Research, Boston, MA, USA; Department of Pediatics, Harvard Medical School, Boston, MA, USA
Departments of Cancer Immunology & AIDS, Dana -Farber Cancer Institute, Boston, MA, USA
Department of Adult Oncology, Dana -Farber Cancer Institute, Boston, MA, USA
Department of Pathology, Harvard Medical School, Boston, MA, USA
Department of Neurology, Harvard Medical School, Boston, MA, USA
Department of Medicine, Harvard Medical School, Boston, MA, USA
Department of Pediatics, Harvard Medical School, Boston, MA, USA

* Corresponding author; email: alper{at}cbr.med.harvard.edu.

We have shown previously that primary dendritic cells and monocytes express equal levels of CD14 but are distinguishable by the presence of CD2 on dendritic cells. CD2 is known to mediate the activation of T and NK cells through its interaction with CD58. CD2 epitopes recognized by anti-T111, -T112 and -T113 mAbs are present on dendritic cells. Here we show that CD2 engagement significantly increases class II, costimulatory (CD40, CD80, CD86), adhesion (CD54, CD58), and CCR7 molecule expression on primary dendritic cells. Conversely, minimal or no change in the expression of the above antigens occurs on monocyte-derived dendritic cells, since these molecules are already maximally expressed. However, both kinds of dendritic cells release IL-1{beta} and IL-12 after CD2 engagement. Lastly, interference with dendritic cell CD2-T cell CD58 engagement decreases naive CD4+CD45RA+ T cell proliferation. Collectively, our results suggest another role of the CD2-CD58 pathway that allows nonimmune and immune cells to interact directly with dendrictic cells and initiate innate and adaptive immune responses.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
H. W. Lim and C. H. Kim
Loss of IL-7 Receptor {alpha} on CD4+ T Cells Defines Terminally Differentiated B Cell-Helping Effector T Cells in a B Cell-Rich Lymphoid Tissue
J. Immunol., December 1, 2007; 179(11): 7448 - 7456.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Di Pucchio, L. Pilla, I. Capone, M. Ferrantini, E. Montefiore, F. Urbani, R. Patuzzo, E. Pennacchioli, M. Santinami, A. Cova, et al.
Immunization of Stage IV Melanoma Patients with Melan-A/MART-1 and gp100 Peptides plus IFN-{alpha} Results in the Activation of Specific CD8+ T Cells and Monocyte/Dendritic Cell Precursors.
Cancer Res., May 1, 2006; 66(9): 4943 - 4951.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. D. Narayan, J. L. Chase, R. L. Lewis, X. Tian, D. S. Kaufman, J. A. Thomson, and E. D. Zanjani
Human embryonic stem cell-derived hematopoietic cells are capable of engrafting primary as well as secondary fetal sheep recipients
Blood, March 1, 2006; 107(5): 2180 - 2183.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Vasir, D. Avigan, Z. Wu, K. Crawford, S. Turnquist, J. Ren, and D. Kufe
Dendritic Cells Induce MUC1 Expression and Polarization on Human T Cells by an IL-7-Dependent Mechanism
J. Immunol., February 15, 2005; 174(4): 2376 - 2386.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2003 by American Society of Hematology         Online ISSN: 1528-0020